MASS
908 Devices Inc. Health Care Laboratory Analytical Instruments Russell 3000
$11.25Close
$408.6MMarket cap
$9.35 – $12.8752-week range
Nov 10, 2026Next report · before the open
Highlights
Cautions
- Results soon Nov 10, 2026, in 9 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
13%
1wk
down 2.1%
price change
1mo
down 8.8%
price change
12-month return
up 11%
total, dividends included
F-score
5 / 9
Mixed
Altman Z
3.95
Low risk
P/E
21.0×
price / earnings
PEG
—
P/E / EPS growth
P/B
2.8×
price / book
Earnings yield
down 11.7%
EBIT / enterprise value
Cheaper than
25%
of the market · expensive
Revenue growth
up 18%
year on year
EPS growth
—
latest quarter
Sales growth
up 23%
latest quarter · +10 pts
ROE
up 15%
return on equity
Free cash margin
down 44%
-$24.6M FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
- operating cash flow is negative
- profits not fully backed by cash
- issued more shares
- gross margin narrowed
- profitable on its assets
- profitability improving
- reduced long-term debt
- short-term liquidity improved
- assets working harder
Repair signals
- Revenue reaccelerating (-5% then +18%)
Trade setup
ATR%
6.1%
$0.69 a day · 2×ATR $9.87
RS
—
vs the universe
Trend
—
trend template
Relative volume
1.4×
vs 50-day average
Up/down volume
1.30
50 sessions
Implied move
—
no option chain · report Nov 10, 2026
Screen verdict
Did not qualify for any screen.
Warning signs
- Shareholders diluted The share count rose 3.5% over the year, from 35m to 36m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
- Profit not backed by cash Reported profit of $19.5M came with -$23.7M of operating cash flow. Profit that cash does not follow is the classic signature of aggressive accounting.
Last reported
Aug 11, 2026
Financials
- Gross 51%
- Net 35%
- Free cash -44%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $26.9M | $42.2M | $46.9M | $50.2M | $47.7M | $56.2M |
| Gross margin | 55% | 55% | 56% | 50% | 51% | 51% |
| Operating income | -$5.8M | -$22.1M | -$35.4M | -$42.8M | -$57.4M | -$39.4M |
| Net income | -$12.8M | -$22.2M | -$33.6M | -$36.4M | -$72.2M | $19.5M |
| Net margin | -48% | -53% | -72% | -72% | -151% | 35% |
| Earnings per share | -$2.34 | -$0.79 | -$1.07 | -$1.13 | -$2.12 | $0.54 |
| Free cash flow | $4.1M | -$29.8M | -$23.0M | -$27.1M | -$30.8M | -$24.6M |
| Free cash margin | 15% | -71% | -49% | -54% | -65% | -44% |
| Cash | $159.2M | $224.1M | $188.4M | $121.0M | $44.0M | $70.5M |
| Long-term debt | $14.3M | $15.0M | $15.0M | — | — | — |
| Shareholders' equity | $139.0M | $214.6M | $190.6M | $165.5M | $114.6M | $143.7M |
| Shares outstanding | 27.27m | 31.08m | 31.86m | 32.52m | 35.10m | 36.32m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 11, 2026 | Quarterly ↗ | Jun 30, 2026 | 42d |
| May 6, 2026 | Quarterly ↗ | Mar 31, 2026 | 36d |
| Mar 9, 2026 | Annual ↗ | Dec 31, 2025 | 68d |
| Nov 10, 2025 | Quarterly ↗ | Sep 30, 2025 | 41d |
| Aug 5, 2025 | Quarterly ↗ | Jun 30, 2025 | 36d |
| May 13, 2025 | Quarterly ↗ | Mar 31, 2025 | 43d |
| Mar 7, 2025 | Annual ↗ | Dec 31, 2024 | 66d |
| Nov 12, 2024 | Quarterly ↗ | Sep 30, 2024 | 43d |
| Aug 6, 2024 | Quarterly ↗ | Jun 30, 2024 | 37d |
| May 3, 2024 | Quarterly ↗ | Mar 31, 2024 | 33d |
| Mar 8, 2024 | Annual ↗ | Dec 31, 2023 | 68d |
| Nov 7, 2023 | Quarterly ↗ | Sep 30, 2023 | 38d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 11, 2026 | Results ↗ |
| Jul 8, 2026 | Other events ↗ |
| Jun 12, 2026 | Shareholder vote ↗ |
| May 6, 2026 | Material agreement · Acquisition or disposal · Results · Unregistered share sale · Regulation FD ↗ |
| Mar 3, 2026 | Results ↗ |
| Jan 20, 2026 | Results ↗ |
| Nov 10, 2025 | Results ↗ |
| Aug 5, 2025 | Results ↗ |
| Aug 4, 2025 | Director or officer change · Regulation FD ↗ |
| Jun 16, 2025 | Director or officer change · Regulation FD ↗ |
| Jun 13, 2025 | Shareholder vote ↗ |
| May 13, 2025 | Results ↗ |